Neuralink opens recruitment for the PRIME study after independent review board approval

Neuralink/N1 implant (Telepathy)

Neuralink received independent review board approval and secured its first hospital site to begin recruiting people with paralysis for the PRIME study. The trial will evaluate the N1 implant and R1 surgical robot safety and assess whether users can control external devices by thought.

• Received approval from independent review board and first hospital site
• Recruiting adults with paralysis from cervical spinal cord injury or ALS
• PRIME study expected to take roughly six years to complete
• Tests safety of N1 implant and R1 robot, plus thought-control functionality